Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Nephrology Dialysis Transplantation (NDT)
Published September 4, 2026
CKD risk with tegoprazan versus proton pump inhibitors.
September 5, 2026
Medspoke
Medspoke
Nephrology Dialysis Transplantation (NDT)
Published September 4, 2026
00:00
--:--
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDEN...
September 5, 2026
Share
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.
https://www.medspoke.co/channel_journal?id=797&tap_id=13665
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Clinical Journal of the American Society of Nephrology (CJASN)
Published September 2, 2026
Randomized Controlled Trial Comparing Lactoferrin Plus Iron to Iron Alone for Iron Deficiency Ane...
September 4, 2026
Why are you reporting this TALK?
